about
Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: A randomized crossover trial.Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryPeer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluationTherapeutic burden in interstitial lung disease: Lessons to learnAnalysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosisEligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingBlood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registryAcute exacerbations in IPF: A clarion call for collaborative researchThe supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic reviewCirculating RNA differences between patients with stable and progressive IPF
P50
Q31159853-7277D813-F990-42B8-B021-86AC53E5ED38Q47687378-385C7DCF-40A6-4E9F-8609-B1D859FCD8A8Q47727383-7F4C6DB8-3ED6-4232-8C52-1F79E1ADC8CDQ47791471-30EBA8BC-A198-4B26-9810-F7D24E528531Q47880915-614356FF-CF8A-41BD-85F5-9A14C27A642FQ57454989-CB0FBF72-A53D-47B8-9216-A2083B12D37FQ90616491-8CC8127B-B2CF-4995-92C5-7CE825C56B3AQ91799170-5BFC9AE3-F7E4-4391-88E9-3AD90630B7A5Q92496856-A847CB73-276B-4D4B-A858-6B7449B0DF3FQ92693570-6AD5E235-DA23-4FBB-8F55-1B2AE59DEBADQ92711364-F44BFD57-E3A2-410E-9BCA-17CD6FE9F0F4Q93045358-A6AEB125-A0FC-4F9A-B97D-6EA966E8B278Q94461344-D4EB91A9-A346-49BD-B6B6-95155698F4FBQ94547025-4AFB63CA-EF5D-477A-AC1C-17677E550F2E
P50
description
researcher
@en
wetenschapper
@nl
name
Ian Glaspole
@en
Ian Glaspole
@nl
type
label
Ian Glaspole
@en
Ian Glaspole
@nl
prefLabel
Ian Glaspole
@en
Ian Glaspole
@nl
P31
P496
0000-0002-5118-2890